The Supreme Court’s 2024 Purdue decision1 held that the Bankruptcy Code does not authorize a release and injunction under a Chapter 11 plan of claims against a non-debtor, even if they relate to claims against or by the...more
1/7/2025
/ Bankruptcy Code ,
Bankruptcy Court ,
Buyback Litigation ,
Chapter 11 ,
Commercial Bankruptcy ,
Corporate Governance ,
Corporate Restructuring ,
Creditors ,
Debtors ,
Harrington v Purdue Pharma L P ,
Insurance Industry ,
Mass Tort Litigation ,
Purdue Pharma ,
SCOTUS
On May 31, 2024, the chief judge of the U.S. Bankruptcy Court for the Southern District of New York (SDNY) entered General Order M-634, adopting guidelines for combining the processes for Chapter 11 plan confirmation under...more
From time to time, the U.S. Supreme Court has distinguished the bankruptcy courts’ power — deriving from Congress’ authority under Article I of the U.S. Constitution to enact uniform bankruptcy laws — from the judicial power...more
Rights offerings have become a key tool for companies in Chapter 11. They can address liquidity needs, help demonstrate plan feasibility and facilitate plan negotiations.
Rights offerings, however, may also serve as...more